Skip to main content
. Author manuscript; available in PMC: 2021 May 11.
Published in final edited form as: Transl Res. 2020 May 31;223:1–14. doi: 10.1016/j.trsl.2020.05.009

Table 1.

Patient demographics and clinical characteristics at baseline

RCC without RITE (n=50) RCC with RITE (n=50) Total
Age*, y, mean (range) 55.6 (52.26–58.94) 60.70 (56.55–64.84) 57.48 (55.03–59.93)
Sex*, n (%)
Male 30 (60) 34 (68) 64 (64)
Female 20 (40) 16 (32) 36 (36)
BMI*, mean (range) 32.53 (29.73–35.33) 29.13 (26.94–31.33) 31.19 (29.28–33.10)
Ethnicity*, n (%)
Hispanic/Latino 35 (71.43) 33 (68.75) 68 (70.1)
Non-Hispanic 14 (28.57) 15 (31.25) 29 (29.9)
Diabetes, n (%)
Yes 24 (48) 18 (36) 42 (42)
No 26 (52) 32 (64) 58 (58)
Hypertension, n (%)
Yes 41 (82) 32 (64) 73 (73)
No 9 (18) 18 (36) 27 (27)
Type of RCC*, n (%)
Clear cell 44 (88) 40 (80) 84 (84)
Non-clear cell 6 (12) 10 (20) 16 (16)
Fuhrman grade*, n (%)
1 2 (4) 0 (0) 2 (2.02)
2 15 (30) 11 (22.45) 26 (26.26)
3 21 (42) 21 (42.86) 42 (42.42)
4 12 (24) 17 (34.69) 29 (29.29)
T stage, n (%)
1 9 (18) 0 (0) 9 (9)
2 11 (22) 0 (0) 11 (11)
3 30 (60) 48 (96) 78 (78)
4 0 (0) 2 (4) 2 (2)
N stage, n (%)
1 1 (2.17) 8 (16.67) 9 (9.57)
0 45 (97.83) 40 (83.33) 85 (90.43)
M stage, n (%)
1 3 (7.32) 9 (20) 12 (13.95)
0 38 (92.68) 36 (80) 74 (86.05)
Tumor volume*, mm3, mean (range) 411.78 (265.95–557.61) 664.13 (446.87–881.39) 525.94 (399.13–652.75)
*

Matched variables. BMI, body mass index; RCC, renal cell carcinoma; RITE, renal intravascular tumor extension